NCT00648193View on ClinicalTrials.gov

Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

January 31, 2007

Conditions
Healthy
Interventions
DRUG

Paroxetine hydrochloride 40 mg tablet

40mg, single dose fasting

DRUG

Paxil® 40 mg Table

40mg, single dose fasting

Trial Locations (1)

63301

Gateway Medical Research, Inc., Saint Charles

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648193 - Fasting Study of Paroxetine Hydrochloride Tablets 40 mg and Paxil® Tablets 40 mg | Biotech Hunter | Biotech Hunter